|
related topics |
{property, intellectual, protect} |
{debt, indebtedness, cash} |
{tax, income, asset} |
{customer, product, revenue} |
{stock, price, share} |
{operation, natural, condition} |
{system, service, information} |
{operation, international, foreign} |
{product, candidate, development} |
{competitive, industry, competition} |
{stock, price, operating} |
{cost, operation, labor} |
{product, market, service} |
{acquisition, growth, future} |
{regulation, change, law} |
{personnel, key, retain} |
|
We have experienced varied operating results, and our operating results for any particular fiscal period are
affected by the timing of significant orders for our software products, fluctuations in customer preferences
for license types and the timing of recognition of revenue under those license types.
Our future revenue is dependent in part upon our installed customer base continuing to license or buy
additional products, renew maintenance agreements and purchase additional services.
We may not receive significant revenue from our current research and development efforts for several years, if at all.
We have acquired and expect to acquire other companies and businesses and may not realize the expected benefits of these acquisitions.
Our failure to attract, train, motivate and retain key employees may make us less competitive in our industries
and therefore harm our results of operations.
The competition in our industries is substantial and we cannot assure you that we will be able to continue
to successfully compete in our industries.
We may need to change our pricing models to compete successfully.
We rely on our proprietary technology as well as software and other intellectual property rights licensed to
us by third parties, and we cannot assure you that the precautions taken to protect our rights will be
adequate or that we will continue to be able to adequately secure such intellectual property rights from
We could lose key technology or suffer serious harm to our business because of the infringement of our
intellectual property rights by third parties or because of our infringement of the intellectual property
If our security measures are breached and an unauthorized party obtains access to customer data, our
information systems may be perceived as being unsecure and customers may curtail their use of, or stop
their use of, our products and services.
We may not be able to effectively implement our restructuring activities, and our restructuring activities
may not result in the expected benefits, which would negatively impact our future results of operations.
The long sales cycle of our products and services makes the timing of our revenue difficult to predict and
may cause our operating results to fluctuate unexpectedly.
The effect of foreign exchange rate fluctuations and other risks to our international operations may
seriously harm our financial condition.
Our operating results could be adversely affected as a result of changes in our effective tax rates.
We have received an examination report from the Internal Revenue Service proposing a tax deficiency in
certain of our tax returns, and the outcome of current and future tax examinations may have a material
adverse effect on our results of operations and cash flows.
Forecasting our estimated annual effective tax rate is complex and subject to uncertainty, and material
differences between forecasted and actual tax rates could have a material impact on our results of
Failure to obtain export licenses could harm our business by rendering us unable to ship products and transfer
our technology outside of the United States.
Errors or defects in our products and services could expose us to liability and harm our reputation.
New accounting standards related to equity compensation will cause us to recognize additional expense.
If we become subject to unfair hiring claims, we could be prevented from hiring needed employees, incur
liability for damages and incur substantial costs in defending ourselves.
Our business is subject to the risk of earthquakes, floods and other natural catastrophic events.
We maintain research and other facilities in parts of the world that are not as politically stable as the
United States, and as a result we may face a higher risk of business interruption from acts of war or
terrorism than businesses located only or primarily in the United States.
Risks Related to Our Securities and Our Debt Obligations
Our debt obligations expose us to risks that could adversely affect our business, operating results and financial
condition, and could prevent us from fulfilling our obligations under such indebtedness.
We may be unable to adequately service our indebtedness, which may result in defaults and other costs to us.
Conversion of the Notes will dilute the ownership interests of existing stockholders.
We may, at the option of the Noteholders and only in certain circumstances, be required to repurchase the
Notes in cash or shares of our common stock.
Convertible notes hedge and warrant transactions entered into in connection with the issuance of the
Notes may affect the value of our common stock.
Full 10-K form ▸
|
|
related documents |
1342126--3/17/2008--Morgans_Hotel_Group_Co. |
1145460--2/29/2008--INVERNESS_MEDICAL_INNOVATIONS_INC |
1073431--3/2/2009--Life_Technologies_Corp |
1073431--2/26/2010--Life_Technologies_Corp |
1342126--3/16/2009--Morgans_Hotel_Group_Co. |
1342126--3/30/2007--Morgans_Hotel_Group_Co. |
1342126--3/31/2006--Morgans_Hotel_Group_Co. |
912241--3/31/2006--PROGRESSIVE_GAMING_INTERNATIONAL_CORP |
912241--3/23/2007--PROGRESSIVE_GAMING_INTERNATIONAL_CORP |
1145460--3/16/2006--INVERNESS_MEDICAL_INNOVATIONS_INC |
1014672--3/12/2010--CALIPER_LIFE_SCIENCES_INC |
1352341--12/19/2008--Verigy_Ltd. |
813672--3/2/2009--CADENCE_DESIGN_SYSTEMS_INC |
1359841--2/9/2010--Hanesbrands_Inc. |
1145460--3/1/2007--INVERNESS_MEDICAL_INNOVATIONS_INC |
813672--2/26/2008--CADENCE_DESIGN_SYSTEMS_INC |
924642--3/15/2007--APPLIED_DIGITAL_SOLUTIONS_INC |
706539--3/16/2006--CHIRON_CORP |
1043961--3/31/2006--TRANSGENOMIC_INC |
320345--8/29/2007--MICROS_SYSTEMS_INC |
813672--2/23/2007--CADENCE_DESIGN_SYSTEMS_INC |
1073431--3/1/2006--INVITROGEN_CORP |
1001193--3/30/2007--TRANSMETA_CORP |
865231--3/1/2007--CELL_GENESYS_INC |
1014672--3/14/2008--CALIPER_LIFE_SCIENCES_INC |
1014672--3/13/2009--CALIPER_LIFE_SCIENCES_INC |
1002607--9/18/2007--ATARI_INC |
869986--6/29/2009--ADVANCED_PHOTONIX_INC |
802356--7/24/2006--PARLUX_FRAGRANCES_INC |
813672--2/26/2010--CADENCE_DESIGN_SYSTEMS_INC |
|